SECOND NOTIFICATION: Discontinuation of Frisium® (clobazam) Tablets in Canada
January 26, 2018 SECOND NOTIFICATION: Discontinuation of Frisium® (clobazam) Tablets in Canada Dear Healthcare Professional and Epilepsy Patient Advocacy Organization, As communicated first in July 2017, after careful consideration, Lundbeck has made the decision to discontinue the manufacturing of Frisium® (clobazam) Tablets in Canada. This decision was not triggered by a safety issue, but rather…